These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 9355843)

  • 1. Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Hägglund H; Winiarski J; Ringdén O; Sparrelid E; Ericzon BG
    Transplantation; 1997 Oct; 64(8):1207-8. PubMed ID: 9355843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful allogeneic bone marrow transplantation in an adult with aplastic anemia following orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Dugan MJ; Rouch DA; Akard LP; Sperl BG; Black JR; Markham RE; Jansen J
    Bone Marrow Transplant; 1993 Oct; 12(4):417-419. PubMed ID: 8275044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful cytokine treatment of aplastic anemia following living-related orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
    Sato S; Fuchinoue S; Abe M; Kitajima K; Tojimbara T; Nakajima I; Agishi T; Shiraga H; Ito K; Takasaki K; Hashimoto E; Hayashi N; Tanaka K
    Clin Transplant; 1999 Feb; 13(1 Pt 1):68-71. PubMed ID: 10081639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful allogeneic bone marrow transplantation in a 6.5-year-old male for severe aplastic anemia complicating orthotopic liver transplantation for fulminant non-A-non-B hepatitis.
    Kawahara K; Storb R; Sanders J; Petersen FB
    Blood; 1991 Aug; 78(4):1140-3. PubMed ID: 1907874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor].
    Fujisaki T; Gondo H; Uchida N; Matsuo I; Takenaka K; Tanimoto K; Otsuka T; Minematsu T; Minamishima Y; Niho Y
    Rinsho Ketsueki; 1997 Feb; 38(2):142-5. PubMed ID: 9059069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
    Kiem HP; McDonald GB; Myerson D; Spurgeon CL; Deeg HJ; Sanders JE; Doney K; Appelbaum FR; Sullivan KM; Witherspoon RP; Storb R
    Biol Blood Marrow Transplant; 1996 May; 2(2):93-9. PubMed ID: 9118304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early treatment of CMV infections in allogeneic bone marrow transplant recipients with foscarnet or ganciclovir.
    Bacigalupo A; van Lint MT; Tedone E; Moro F; Sanna MA; Longren M; Trespi G; Frassoni F; Occhini D; Gualandi F
    Bone Marrow Transplant; 1994 Jun; 13(6):753-8. PubMed ID: 7920310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir-resistant cytomegalovirus encephalitis in a bone marrow transplant recipient.
    Julin JE; van Burik JH; Krivit W; Webb C; Holman CJ; Clark HB; Balfour HH
    Transpl Infect Dis; 2002 Dec; 4(4):201-6. PubMed ID: 12535263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tacrolimus (FK506) in allogeneic bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation.
    Trede NS; Warwick AB; Rosoff PM; Rohrer R; Bierer BE; Guinan E
    Bone Marrow Transplant; 1997 Aug; 20(3):257-60. PubMed ID: 9257897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful hematopoietic stem cell transplantation for aplastic anemia following living-related liver transplantation.
    Umeda K; Adachi S; Watanabe K; Kimura N; Lin Y; Nakahata T
    Bone Marrow Transplant; 2002 Oct; 30(8):531-4. PubMed ID: 12379894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients.
    Mattes FM; Hainsworth EG; Geretti AM; Nebbia G; Prentice G; Potter M; Burroughs AK; Sweny P; Hassan-Walker AF; Okwuadi S; Sabin C; Amooty G; Brown VS; Grace SC; Emery VC; Griffiths PD
    J Infect Dis; 2004 Apr; 189(8):1355-61. PubMed ID: 15073671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature.
    Itterbeek P; Vandenberghe P; Nevens F; Fevery J; Aerts R; Yap SH; Demuynck H; Fourneau I; Koshiba T; Emonds MP; Roskams T; Boogaerts M; Pirenne J
    Transpl Int; 2002 Mar; 15(2-3):117-23. PubMed ID: 11935168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Stocchi R; Ward KN; Fanin R; Baccarani M; Apperley JF
    Haematologica; 1999 Jan; 84(1):71-9. PubMed ID: 10091394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful bone marrow transplantation for severe aplastic anemia following orthotopic liver transplantation: long-term follow-up and outcome.
    Perkins JL; Neglia JP; Ramsay NK; Davies SM
    Bone Marrow Transplant; 2001 Sep; 28(5):523-6. PubMed ID: 11593328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganciclovir prophylaxis for cytomegalovirus infection in pediatric allogeneic bone marrow transplant recipients.
    Canpolat C; Culbert S; Gardner M; Whimbey E; Tarrand J; Chan KW
    Bone Marrow Transplant; 1996 Apr; 17(4):589-93. PubMed ID: 8722360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double bone marrow transplantation for severe aplastic anemia after orthotopic liver transplantation: implications for clinical management and immune tolerance.
    Stachel D; Schmid I; Lang T; Haas RJ; Otté JB
    Transpl Int; 2002 Jan; 15(1):39-44. PubMed ID: 11875612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
    Ljungman P; Loré K; Aschan J; Klaesson S; Lewensohn-Fuchs I; Lönnqvist B; Ringdén O; Winiarski J; Ehrnst A
    Bone Marrow Transplant; 1996 Apr; 17(4):583-7. PubMed ID: 8722359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow failure in children with acute liver failure.
    Tung J; Hadzic N; Layton M; Baker AJ; Dhawan A; Rela M; Heaton ND; Mieli-Vergani G
    J Pediatr Gastroenterol Nutr; 2000 Nov; 31(5):557-61. PubMed ID: 11144443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report.
    Iwami D; Ogawa Y; Fujita H; Morita K; Sasaki H; Oishi Y; Higuchi H; Hatanaka K; Shinohara N
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():63-6. PubMed ID: 26970406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.